Nextrials, Inc. Sees Increase in Registry Studies

SAN RAMON, Calif.--(BUSINESS WIRE)--Nextrials, Inc. (www.nextrials.com), a leader in clinical research software and services, is experiencing an upswing in registry studies, thanks in part to the flexibility of its electronic data capture (EDC) and clinical trial data management platform, Prismâ„¢. With key features that include flexible form design with conditional fields and start page customization to facilitate branding and ad hoc reporting, Prism gives sponsors a powerful platform for mining registry study patient data via a very user-friendly interface.

Back to news